Medtronic Starts New U.S. Study of Endurant AAA Stent Graft

Comments
Loading...
Leading the development of endovascular aortic repair, Medtronic, Inc. MDT today announced the start of its U.S. post-approval study of the Endurant AAA Stent Graft System, a medical device used to treat abdominal aortic aneurysms.
MDT Logo
MDTMedtronic PLC
$92.74-0.57%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum72.25
Growth62.61
Quality44.05
Value20.78
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs

Posted In: